Clinical Research

Celon Pharma S.A.

Address
Ul. Ogrodowa 2a, Kielpin

Sponsor Overview

assignment
5
sponsored trials
science
1
molecule
location_city
2
research centres
public
1
country
person_search
1
investigator

Specializations

Respiratory medicine

Clinical research includes maintenance bronchodilator treatment for adults with chronic obstructive pulmonary disease (COPD), with interest in inhaled therapies used to ease persistent respiratory symptoms.

  • Chronic obstructive pulmonary disease
  • Maintenance bronchodilation
  • Inhaled combination therapy

The respiratory portfolio reflects a focus on treatments intended to support ongoing symptom control in long-term obstructive airway disease.

Cardiovascular disease

The sponsor is active in studies related to atherothrombotic prevention for adults with acute coronary syndromes (ACS) and for patients with a history of myocardial infarction (MI) at elevated risk of recurrent events.

  • Acute coronary syndromes
  • Myocardial infarction
  • Atherothrombotic event prevention

Work in this area centres on antithrombotic therapies relevant to secondary prevention in high-risk cardiovascular populations.

Stroke prevention and atrial fibrillation

Research activity also covers prevention of stroke and systemic embolism in adults with non-valvular atrial fibrillation (NVAF) and additional risk factors such as prior transient ischaemic attack (TIA), advanced age, hypertension, diabetes mellitus, and symptomatic heart failure.

  • Non-valvular atrial fibrillation
  • Stroke prevention
  • Systemic embolism

This area links anticoagulant development with prevention of thromboembolic complications in patients with cardiac rhythm disorders.

Venous thromboembolism

Additional trials address treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE), together with prevention of recurrent venous thromboembolic events in adults.

  • Deep vein thrombosis
  • Pulmonary embolism
  • Recurrent venous thromboembolism

The therapeutic emphasis in this field is on anticoagulant management for acute and secondary prevention of venous clotting disorders.

Sponsored Trials

Trial Name Country Status
Bioequivalence Study of Apixaban 5 mg Hard Capsules vs. Film-Coated Tablets in Healthy Volunteers Under Fasting ConditionsPoland PolandNot Recruiting
Bioequivalence Study of Indacaterol/Glycopyrronium Inhalation Powder in Adult COPD Patients: PG341 vs. Ultibro BreezhalerPoland PolandNot Recruiting
Bioequivalence Study of Ticagrelor 90 mg Hard Capsules Versus Film-Coated Tablets in Healthy Volunteers for Atherothrombotic Event PreventionPoland PolandNot Recruiting
Evaluation of PG413 Versus Apixaban in the Prevention of Stroke and Systemic Embolism in Adults with Non-Valvular Atrial Fibrillation and Treatment of ThromboembolismPoland PolandNot Recruiting
Randomized crossover study of PG511/PG521/PG531 versus PG203 in healthy volunteers: safety, tolerability, PK for schizophrenia & levodopa‑induced dyskinesiaPoland PolandRecruiting

Data & Insights

science
Molecule Portfolio
Compounds under investigation
0
Exclusive Molecules
out of 1 total (0% not shared with other sponsors)

This sponsor works with 1 molecule, of which 0 are not being studied by other sponsors.

hub
Site Partnerships
Collaboration with research centres
50%
Return partnership rate
1 of 2 sites collaborated multiple times

This sponsor has worked with 2 sites across their trial portfolio.

Therapeutic Focus

  • 1.
    Cardiovascular Diseases3 trials
    359 other sponsors
  • 2.
    Mental Disorders1 trial
    150 other sponsors
  • 3.
    Nervous System Diseases1 trial
    449 other sponsors
  • 4.
    Respiratory Tract Diseases1 trial
    277 other sponsors

Partnered Research Centres

2 centres
location_city
assignment1
Bioresearch Group Sp. z o.o.
Address
Ul. Sokolowska 9/u2, 01-142 Warsaw
Learn morearrow_forward
location_city
assignment6
Bioresearch Group Sp. z o.o.
Address
Ul. Sokolowska 9/u2, 01-142 Nadarzyn
Learn morearrow_forward

Want to get in touch with this sponsor?

Send a question and we'll pass it on to Celon Pharma S.A..

Need a custom report on this sponsor?

Competitive positioning, market entry, partnership opportunities — tell us the question.

Is something out of date?

Tell us what needs correcting and we'll update this profile.